首页> 外文OA文献 >Surgical treatment for diffused-type giant cell tumor (pigmented villonodular synovitis) about the ankle joint
【2h】

Surgical treatment for diffused-type giant cell tumor (pigmented villonodular synovitis) about the ankle joint

机译:关于踝关节的扩散型巨细胞肿瘤(着色绒毛沉膜炎)的外科治疗

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background Diffused-type giant cell tumor(Dt-GCT) is a rare, aggressive disorder of the joint synovium, bursa and tendon sheaths. Osseous erosions and subchondral cysts may develop as the result of synovium infiltration in Dt-GCT. We present a retrospective study of a series of patients who are diagnosed with Dt-GCT about the ankle joint, there clinical outcome is evaluated in this study. Material and method Fifteen patients with radiologically and histologically confirmed Dt-GCT about the ankle joint were identified in our foot and ankle department. Patients were managed with open synovectomy for the tumor tissue and bone grafting for bony erosions. X-rays and MRI scans were used for evaluation of the tumor and bony erosions pre- and post-operatively. Pre- and post-operative ankle function was assessed using the American Orthopedic Foot and Ankle Society –Ankle and Hindfoot (AOFAS-AH) score and the Muscularskeletal Tumor Society (MSTS) score. Results The mean follow-up duration was 37.4 months (range 25 to 50 months). There were 6 males and 9 females, with a mean age of 35 years old (range 18 to 65 years). All patients had talar erosion with the average size of 10.1*9.1*8.2 mm, distal tibia was affected in 5 patients with the average size of 6.2*5.6*5.8 mm. 7 patients had tendon involvement, 2 patients had recurrence and progression of ankle osteoarthritis. Both of them underwent ankle fusion. At the time of last follow-up, the mean AOFAS-AH score increased from 49 to 80 points (p < 0.05), the MSTS score increased from 12 to 22 points (p < 0.05). Conclusion For Dt-GCT with bony erosions, open synovectomy combined with bone grafting seems to be a safe and effective operation for the salvage of ankle joint. Fusion is recommended for failed and severe cartilage destruction of the ankle joint.
机译:摘要背景扩散型巨细胞肿瘤(DT-GCT)是联合滑膜,Bursa和肌腱护套的罕见,侵蚀性障碍。由于DT-GCT的渗透结果,骨质糜烂和子骨质囊肿可能会产生。我们展示了一系列诊断患有DT-GCT的一系列患者关于踝关节的患者的回顾性研究,在本研究中评估了临床结果。在我们的脚和脚踝部门鉴定了关于踝关节的放射学和组织学和组织学证实的DT-GCT的材料和方法。患者用Open Soneovectomy进行管理,用于肿瘤组织和骨侵蚀的骨腐蚀。 X射线和MRI扫描用于预先和可操作地对肿瘤和骨腐蚀的评估。使用美国矫形脚和脚踝社会 - 和Hindfoot(Aofas-AH)评分和肌肉骨骼肿瘤会(MSTS)得分预先评估了术前和后踝关节功能。结果平均随访时间为37.4个月(25至50个月)。有6个男性和9名女性,平均年龄为35岁(范围为18至65岁)。所有患者均具有10.1 * 9.1 * 8.2毫米的平均大小,远端胫骨受到5例6.2 * 5.6 * 5.8 mm的5例患者的影响。 7例患者肌腱受累,2名患者复发和踝关节骨关节炎的进展。他们俩都接受了脚踝融合。在最后一次随访时,平均AOFAS-AH评分从49到80点(p <0.05)增加,MSTS评分从12到22点(p <0.05)增加。结论DT-GCT与骨糜烂,开放的涂膜结合骨移植似乎是踝关节挽救的安全有效操作。建议融合踝关节的失败和严重的软骨破坏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号